FDA urged to preserve antibacterial products, ingredients

American Cleaning Institute is asking the Food and Drug Administration to re-evaluate antibacterial data


The Food and Drug Administration (FDA) is being urged to re-evaluate data relevant to the safety and efficacy of antibacterial healthcare ingredients, according to an article on the Infection Control Today website.

The American Cleaning Institute (ACI) is asking the FDA to make affirmative findings that they are generally recognized as safe and effective.

“The active ingredients used in healthcare antiseptic drug products have very favorable benefit/risk ratios demonstrated over many years of extensive use,” according to Dr. Paul DeLeo, ACI associate vice president of environmental safety. 

ACI also asked the FDA not to change safety classifications of several key antibacterial ingredients

Read the article.

 

 



November 10, 2015


Topic Area: Industry News


Recent Posts

17 Million Patient Records Stolen in PIH Health Ransomware Attack

A ransomware attack halted operations across three of PIH’s hospitals.


Holidays are Prime Times for Healthcare Cyberattacks

A study found that 86 percent of organizations that experienced ransomware attacks were targeted on a holiday or weekend.


Hartford Healthcare Forms Partnership to Open Health Equity Clinic

The new clinic will open in January 2025.


UCHealth Reveals Plans for Memorial Hospital North Expansion

Construction on the patient tower is slated for 2026 with a projected opening to patients in 2029.


What Are 'Hospi-tels'?

Hospitals and hotels are partnering to better cater to patients and families.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.